Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 24
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/13/2007
 
First Published:
1/5/2007
1.
Phase I/II Study of Paclitaxel and Ifosfamide Followed By Paclitaxel, Carboplatin, and Ifosfamide With Autologous Peripheral Blood Stem Cell Support in Patients With Cisplatin-Resistant Germ Cell Tumor
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
NCI
MSKCC-06077
NCT00423852
Last Modified:
5/22/2008
 
First Published:
5/4/2007
2.
Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
Any age
NCI
CINJ-3330
NCT00161187
Last Modified:
8/5/2008
 
First Published:
5/1/2007
3.
Phase II Study of Combination Chemotherapy and Pegfilgrastim in Patients With Previously Untreated Germ Cell Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
MSKCC-07044
07-044, NCT00470366
Last Modified:
10/22/2008
 
First Published:
2/28/2008
4.
Phase II Study of Tandem High-Dose Chemotherapy in Combination With Autologous Hematopoietic Stem Cell Transplantation in Patients With Germ Cell Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
16 and over
NCI
CHNMC-07156
07156, NCT00627601
5.
Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 to 78
Pharmaceutical / Industry
OVAR0801
NCT00753740
Last Modified:
6/7/2007
 
First Published:
2/12/2007
6.
Phase I Study of Adjuvant pNGVL3-hICD Vaccine and Sargramostim in Patients With HER2/neu-Overexpressing Stage III or IV Breast or Ovarian Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
UWASH-01-9773-D07
NCT00436254
7.
Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
Other
06C.549
NCT00437372
8.
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
Pharmaceutical / Industry
0602 Oral Picoplatin
NCT00465725
9.
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
45 and under
Other
2004-0079
NCT00502892
10.
Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
Pharmaceutical / Industry
VAC07001
NCT00585845
Select All on One Page
1
2
3
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute